Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2317848,Alcrsp21,Alcohol response QTL 21,1.899999976158142,0.05,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),19,1044648,46044648,Rat,n/a,region,qtl 1000,61350,Bp32,Blood pressure QTL 32,,0.012,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),19,24818257,62275575,Rat,n/a,region,qtl 1000,7411549,Bw130,Body weight QTL 130,5,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),19,19177495,62275575,Rat,n/a,region,qtl 1000,8694186,Bw152,Body weight QTL 152,3.34,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),19,3701835,48701835,Rat,n/a,region,qtl 1000,1354633,Bw28,Body weight QTL 28,6.04,,body mass (VT:0001259),body weight (CMO:0000012),19,31194301,41686140,Rat,n/a,region,qtl 1000,61423,Cia14,Collagen induced arthritis QTL 14,3,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),19,11303927,47879277,Rat,n/a,region,qtl 1000,2298478,Eau8,Experimental allergic uveoretinitis QTL 8,,0.0163,uvea integrity trait (VT:0010551),experimental autoimmune uveitis score (CMO:0001504),19,21407787,62275575,Rat,n/a,region,qtl 1000,1354607,Gmadr1,Adrenal mass QTL 1,5.83,,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),19,31194301,41686140,Rat,n/a,region,qtl 1000,1358200,Insglur2,Insulin/glucose ratio QTL 2,4.1,,blood glucose amount (VT:0000188),serum glucose level (CMO:0000543),19,37916799,60220451,Rat,n/a,region,qtl 1000,1358200,Insglur2,Insulin/glucose ratio QTL 2,4.1,,blood glucose amount (VT:0000188),serum insulin level (CMO:0000358),19,37916799,60220451,Rat,n/a,region,qtl 1000,724546,Kidm3,Kidney mass QTL 3,3.1,,kidney mass (VT:0002707),calculated kidney weight (CMO:0000160),19,32994392,62275575,Rat,n/a,region,qtl 1000,1331788,Rf45,Renal function QTL 45,2.818,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal blood flow rate (CMO:0001168),19,17028003,52538299,Rat,n/a,region,qtl 1000,1354600,Salc2,Saline consumption QTL 2,9.91,0.001,drinking behavior trait (VT:0001422),saline drink intake rate (CMO:0001627),19,31194301,41686140,Rat,n/a,region,qtl 1000,9589102,Slep13,Serum leptin concentration QTL 13,4.63,0.001,blood leptin amount (VT:0005667),plasma leptin level (CMO:0000781),19,3701835,48701835,Rat,n/a,region,qtl 1000,1578764,Stresp19,Stress response QTL 19,3.6,0.001,blood renin amount (VT:0003349),plasma renin activity level (CMO:0000116),19,18993982,62275575,Rat,n/a,region,qtl 1000,61447,Tcas1,Tongue tumor susceptibility QTL 1,6.08,,tongue integrity trait (VT:0010553),squamous cell carcinoma of the tongue maximum tumor diameter (CMO:0001875),19,1957707,46957707,Rat,n/a,region,qtl 1000,724565,Tcas5,Tongue tumor susceptibility QTL 5,10.04,,tongue integrity trait (VT:0010553),number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950),19,5007571,43907843,Rat,n/a,region,qtl 1000,1549835,Tcas7,Tongue tumor susceptibility QTL 7,,0.001,tongue integrity trait (VT:0010553),squamous cell carcinoma of the head and neck tumor number (CMO:0001876),19,24455726,43907843,Rat,n/a,region,qtl 1000,724566,Uae12,Urinary albumin excretion QTL 12,5,,urine albumin amount (VT:0002871),urine albumin level (CMO:0000130),19,2432963,62275575,Rat,n/a,region,qtl 1000,724518,Uae19,Urinary albumin excretion QTL 19,5.5,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),19,8072545,47318201,Rat,n/a,region,qtl 1000,1331737,Uae29,Urinary albumin excretion QTL 29,5.5,,urine albumin amount (VT:0002871),urine albumin level (CMO:0000130),19,6506761,60220581,Rat,n/a,region,qtl 1000,7247442,Uae39,Urinary albumin excretion QTL 39,,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),19,2432963,47217667,Rat,n/a,region,qtl